Stress echocardiography: Superior to scintigraphy in evaluation of coronary disease;Stress-Echokardiographie versus Szintigraphie zur Beurteilung der koronaren Herzkrankheit: Die Stress-Echokardiographie ist uberlegen

Schweizerische Medizinische Wochenschrift

Volumn 127, Issue 50, 1997, Pages 2078-2083

  Buser, P T ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; EXERCISE TEST; HEART SCINTISCANNING; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; REVIEW;

CORONARY CIRCULATION; CORONARY DISEASE; ECHOCARDIOGRAPHY; EXERCISE TEST; HEMODYNAMIC PROCESSES; HUMANS; MYOCARDIAL INFARCTION; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031463642     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. El-Said M, Roelandt JRTC, Fioretti, PM, McNeill AJ, Forster T et al.: Abnormal left ventricular early diastolic filling dobutamine stress Doppler echocardiography is a sensitive indicator of significant coronary artery disease. J Am Coll Cardiol 1994; 24: 1518-1524.
2. Gould KL: Myocardial viability: What does it mean and how to measure it? Circulation 1991; 83: 333-335.
3. Picano E: Stress echocardiography. Second edition. New York: Springer, 1996: 128-143.
4. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O: Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994; 23: 617-626.
5. Vanoverschelde JJ, D'Hondt A, Marwick T, Gerber B, De Kock M et al.: Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low-dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 1996; 28: 432-442.
6. Buser PT, Osswald S, Rickenbacher P, Burckhardt D, Pfisterer M: Risikostratifizierung nach akutem Myokardinfarkt. Schweiz Med Wochenschr 1996; 126: 1011-1022.
7. Picano E, Landi P, Bolognese L, Chiaranda G, Chiarella F et al.: Prognostic value of dipyridamole-echocardiography early after uncomplicated myocardial infarction: a large scale multicenter trial. Am J Med 1993; 11: 608-618.
8. Sicari S, Lusa AM, Salustri A, Mangialardi N, del Rosso G et al.: The value of dipyridamole echocardiography in risk stratification before vascular surgery. J Am Coll Cardiol 1994; 23: 308A.
9. Davila-Roman VG, Waggoner AD, Sicard GA, Geltman EM, Schlechtman KB, Perez JE: Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular disease. J Am Coll Cardiol 1993; 21: 957-963.
10. Shaw LJ, Eagle KA, Gersh BJ, Miller DD: Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985-1994) and dobutamine echocardiography (1991-1994) for risk stratification before vascular surgery. J Am Coll Cardiol 1996; 27: 787-798.
11. Elhendy A, Trocino G, Salustri A, Cornel JH, Roelandt JRTC et al.: Low-dose dobutamine echocardiography and rest-redistribution thallium-201-tomography in the assessment of spontaneous recovery of left ventricular function after recent myocardial infarction. Am Heart J 1996; 131: 1088-1096.
12. Cornel JH, Balk AHMM, Boersma E, Maat APWM, Elhendy A et al.: Safety and feasibility of dobutamine-atropine stress echocardiography in patients with ischemic left ventricular dysfunction. J Am Soc Echocardiogr 1996; 9: 27-32.
13. Poldermans D, Fioretti PM, Boersma E, Forster T, van Urk H et al.: Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease. Am J Cardiol 1994; 73: 456-459.
14. Anthopoulos LP, Bonou MS, Kardaras FG, Sioras EP, Kardara DN et al.: Stress echocardiography in elderly patients with coronary artery disease. Applicability, safety and prognostic value of dobutamine and adenosine echocardiography in elderly patients. J Am Coll Cardiol 1996; 28: 52-59.
15. Trippi JA, Kopp G, Lee KS, Mornson H, Risk G et al.: The feasibility of dobutamine stress echocardiography in the emergency department with telemedicine interpretation. J Am Soc Echocardiogr 1996; 9: 113-118.
16. Sawada SG, Segar DS, Ryan T et al.: Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 1991; 83: 1605-1614.
17. Cohen JL, Greene TO, Ottenweller J, Binenbaum SZ, Wilchfort SD, Kim CS: Dobutamine digital echocardiography for detecting coronary artery disease. Am J Cardiol 1991; 67: 1311-1318.
18. Mazeika PK, Nadazdin A, Oakley CM: Dobutamine stress echocardiography for detection and assessment of coronary artery disease. J Am Coll Cardiol 1992; 19: 1203-1211.
19. Marcovitz PA, Armstrong WF: Accuracy of dobutamine stress echocardiography in detecting coronary artery disease. Am J Cardiol 1992; 69: 1269-1273.
20. Segar DS, Brown SE, Sawada SG, Ryan T, Feigenbaum H: Dobutamine stress echocardiography: correlation with coronary lesion severity as determined by quantitative angiography. J Am Coll Cardiol 1992; 19: 1197-1202.
21. McNeill AJ, Fioretti PM, El-Said M et al.: Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol 1992; 70: 41-46.
22. 99mTc-MIBI single photon emission computed tomography. Circulation 1993; 87: 345-354.
23. Takeuchi M, Araki M, Nakashima Y, Kuroiwa A: Comparison of dobutamine stress echocardiography and stress thallium-201 single-photon emission computed tomography for detecting coronary artery disease. J Am Soc Echocardiogr 1993; 6: 593-602.